Company intelligence / Profile preview

AZAD Pharma AG

Schaffhausen, Schaffhausen, Switzerlandazad.ch ↗

Ownership: Private
Employees: ~66
Development stage: Commercial

Overview

AZAD Pharma AG develops and supplies generic active pharmaceutical ingredients (APIs) and finished drug products using proprietary processes to circumvent patent barriers. The company specializes in value-added formulations such as preservative-free ophthalmic and oncological medicines with minimal side effects. It operates globally with offices in Switzerland, Armenia, Canada, and China.[1][2][4][5]

Therapeutic areas: OtherOphthalmologyOncology
Modalities: Small molecules (generic APIs and finished products)[1][4][5]Injectable and ophthalmic dosage forms[5]
Industry: Biotech

Partnerships

Works with European, Chinese, Indian companies for development/manufacturing partnerships.[5] No major pharma partnerships specifically named.

Beyond the preview

Go deeper on AZAD Pharma AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AZAD Pharma AG.

Explore the full profile